tiprankstipranks
Cardinal Health (DE:CLH)
XETRA:CLH
Germany Market
CLH
Cardinal Health
RESEARCH TOOLSreports

Cardinal Health (CLH) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

CLH Analyst Ratings

Strong Buy
8Ratings
Strong Buy
7 Buy
1 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Cardinal
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CLH Stock 12 Month Forecast

Average Price Target

€227.57
▲(12.44% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Cardinal Health in the last 3 months. The average price target is €227.57 with a high forecast of €238.86 and a low forecast of €208.46. The average price target represents a 12.44% change from the last price of €202.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"124":"€124","239":"€239","152.75":"€152.8","181.5":"€181.5","210.25":"€210.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":238.8620795,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€238.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":227.57041756,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€227.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":208.4614512,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€208.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[124,152.75,181.5,210.25,239],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,198.7,201.7893907307692,204.87878146153844,207.9681721923077,211.05756292307692,214.14695365384614,217.23634438461536,220.32573511538462,223.41512584615384,226.50451657692307,229.5939073076923,232.68329803846154,235.77268876923077,{"y":238.8620795,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,198.7,200.9208013507692,203.14160270153846,205.36240405230768,207.58320540307693,209.80400675384615,212.02480810461537,214.24560945538462,216.46641080615385,218.68721215692307,220.90801350769232,223.12881485846154,225.3496162092308,{"y":227.57041756,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,198.7,199.45088086153845,200.2017617230769,200.95264258461538,201.70352344615384,202.4544043076923,203.20528516923076,203.95616603076923,204.7070468923077,205.45792775384615,206.2088086153846,206.95968947692307,207.71057033846154,{"y":208.4614512,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":131.919,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.684,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.513,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.096,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":180.663,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.209,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.031,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.989,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.207,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.875,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.986,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.7,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€238.86Average Price Target€227.57Lowest Price Target€208.46
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on DE:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
08/03/26
Analysts Conflicted on These Healthcare Names: Guardant Health (NASDAQ: GH) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on DE:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
€208.46
Buy
2.99%
Upside
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), NeuroPace (NASDAQ: NPCE) and Cardinal Health (NYSE: CAH)
Citi Analyst forecast on DE:CLH
Daniel Grosslight
Citi
Citi
€212.8→€230.18
Buy
13.72%
Upside
Reiterated
07/24/26
Cardinal Health price target raised to $265 from $245 at CitiCardinal Health price target raised to $265 from $245 at Citi
Bank of America Securities Analyst forecast on DE:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
€225.83
Buy
11.58%
Upside
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on DE:CLH
Kevin Caliendo
UBS
UBS
€225.83→€237.99
Buy
17.59%
Upside
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
TD Cowen Analyst forecast on DE:CLH
Charles Rhyee
TD Cowen
TD Cowen
€221.49→€238.86
Buy
18.01%
Upside
Reiterated
07/09/26
Cardinal Health price target raised to $275 from $255 at TD CowenCardinal Health price target raised to $275 from $255 at TD Cowen
William O'Neil Analyst forecast on DE:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Barclays Analyst forecast on DE:CLH
Glen Santangelo
Barclays
Barclays
€224.1
Buy
10.72%
Upside
Reiterated
06/10/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
Morgan Stanley Analyst forecast on DE:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
€221.49
Buy
9.43%
Upside
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on DE:CLH
Steven Silver
Argus Research
Argus Research
€215.41
Buy
6.43%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on DE:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
€211.07→€186.75
Hold
-7.73%
Downside
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on DE:CLH
Eric Coldwell
Robert W. Baird
Robert W. Baird
€223.23→€215.41
Buy
6.43%
Upside
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
Evercore ISI Analyst forecast on DE:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€208.46
Buy
2.99%
Upside
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
William Blair Analyst forecast on DE:CLH
Max Smock
William Blair
William Blair
―
Buy
―
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on DE:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
€222.36
Buy
9.86%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on DE:CLH
George Hill
Deutsche Bank
Deutsche Bank
―
Hold
―
Reiterated
08/03/26
Analysts Conflicted on These Healthcare Names: Guardant Health (NASDAQ: GH) and Cardinal Health (NYSE: CAH)
Mizuho Securities Analyst forecast on DE:CLH
Steven Valiquette
Mizuho Securities
Mizuho Securities
€208.46
Buy
2.99%
Upside
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), NeuroPace (NASDAQ: NPCE) and Cardinal Health (NYSE: CAH)
Citi Analyst forecast on DE:CLH
Daniel Grosslight
Citi
Citi
€212.8→€230.18
Buy
13.72%
Upside
Reiterated
07/24/26
Cardinal Health price target raised to $265 from $245 at CitiCardinal Health price target raised to $265 from $245 at Citi
Bank of America Securities Analyst forecast on DE:CLH
Allen Lutz
Bank of America Securities
Bank of America Securities
€225.83
Buy
11.58%
Upside
Reiterated
07/20/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NASDAQ: NEOG) and Cardinal Health (NYSE: CAH)
UBS Analyst forecast on DE:CLH
Kevin Caliendo
UBS
UBS
€225.83→€237.99
Buy
17.59%
Upside
Assigned
07/20/26
Cardinal Health price target raised to $274 from $260 at UBSCardinal Health price target raised to $274 from $260 at UBS
TD Cowen Analyst forecast on DE:CLH
Charles Rhyee
TD Cowen
TD Cowen
€221.49→€238.86
Buy
18.01%
Upside
Reiterated
07/09/26
Cardinal Health price target raised to $275 from $255 at TD CowenCardinal Health price target raised to $275 from $255 at TD Cowen
William O'Neil Analyst forecast on DE:CLH
Unknown Analyst
William O'Neil
Not Ranked
William O'Neil
―
Buy
―
Initiated
06/12/26
Cardinal Health (CAH) Gets a Buy from William O'Neil
Barclays Analyst forecast on DE:CLH
Glen Santangelo
Barclays
Barclays
€224.1
Buy
10.72%
Upside
Reiterated
06/10/26
Barclays Keeps Their Buy Rating on Cardinal Health (CAH)
Morgan Stanley Analyst forecast on DE:CLH
Erin Wright
Morgan Stanley
Morgan Stanley
€221.49
Buy
9.43%
Upside
Reiterated
05/05/26
Cardinal Health (CAH) Gets a Buy from Morgan Stanley
Argus Research Analyst forecast on DE:CLH
Steven Silver
Argus Research
Argus Research
€215.41
Buy
6.43%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH) and Dexcom (NASDAQ: DXCM)
J.P. Morgan Analyst forecast on DE:CLH
Lisa Gill
J.P. Morgan
J.P. Morgan
€211.07→€186.75
Hold
-7.73%
Downside
Assigned
05/04/26
Cardinal Health price target lowered to $215 from $243 at JPMorganCardinal Health price target lowered to $215 from $243 at JPMorgan
Robert W. Baird Analyst forecast on DE:CLH
Eric Coldwell
Robert W. Baird
Robert W. Baird
€223.23→€215.41
Buy
6.43%
Upside
Reiterated
05/01/26
Cardinal Health price target lowered to $248 from $257 at BairdCardinal Health price target lowered to $248 from $257 at Baird
Evercore ISI Analyst forecast on DE:CLH
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
€208.46
Buy
2.99%
Upside
Reiterated
05/01/26
Evercore ISI Remains a Buy on Cardinal Health (CAH)
William Blair Analyst forecast on DE:CLH
Max Smock
William Blair
William Blair
―
Buy
―
Initiated
04/28/26
Cardinal Health Earns Buy Rating on High-Margin Growth Segments and Double-Digit EPS Outlook
Wells Fargo Analyst forecast on DE:CLH
Stephen Baxter
Wells Fargo
Wells Fargo
€222.36
Buy
9.86%
Upside
Assigned
04/13/26
Wells Fargo Gives a Buy Rating to Cardinal Health (CAH)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cardinal Health

3 Months
Eric ColdwellRobert W. Baird
Success Rate
20/27 ratings generated profit
74%
Average Return
+6.33%
Copying Eric Coldwell's trades and holding each position for 3 Months would result in 74.07% of your transactions generating a profit, with an average return of +6.33% per trade.
1 Year
Kevin CaliendoUBS
Success Rate
19/19 ratings generated profit
100%
Average Return
+29.14%
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.14% per trade.
2 Years
Kevin CaliendoUBS
Success Rate
19/19 ratings generated profit
100%
Average Return
+70.79%
Copying Kevin Caliendo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +70.79% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLH Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
17
13
14
16
9
Hold
2
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
14
15
17
10
In the current month, CLH has received 9 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CLH average Analyst price target in the past 3 months is 227.57.
Each month's total comprises the sum of three months' worth of ratings.

CLH Financial Forecast

CLH Earnings Forecast

Next quarter’s earnings estimate for CLH is €2.09 with a range of €2.07 to €2.13. The previous quarter’s EPS was €2.74. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 44.90% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s earnings estimate for CLH is €2.09 with a range of €2.07 to €2.13. The previous quarter’s EPS was €2.74. CLH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 44.90% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Sales Forecast

Next quarter’s sales forecast for CLH is €56.35B with a range of €55.41B to €57.75B. The previous quarter’s sales results were €52.71B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 58.33% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.
Next quarter’s sales forecast for CLH is €56.35B with a range of €55.41B to €57.75B. The previous quarter’s sales results were €52.71B. CLH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 58.33% of the time in the same period. In the last calendar year CLH has Performed in-line its overall industry.

CLH Stock Forecast FAQ

What is DE:CLH’s average 12-month price target, according to analysts?
Based on analyst ratings, Cardinal Health’s 12-month average price target is 227.57.
    What is DE:CLH’s upside potential, based on the analysts’ average price target?
    Cardinal Health has 12.44% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Cardinal Health a Buy, Sell or Hold?
          Cardinal Health has a consensus rating of Strong Buy, which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Cardinal Health’s share price target?
            The average share price target for Cardinal Health is 227.57. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €238.86 ,and the lowest forecast is €208.46. The average share price target represents 12.44% Increase from the current price of €202.4.
              What do analysts say about Cardinal Health?
              Cardinal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of Cardinal Health?
                To buy shares of DE:CLH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.